UCB Korea's Xyzal highly effective for rhinitis.

Published: 2005-05-16 06:58:00

Updated: 2005-05-16 06:58:00

UCB Korea said that in the study for 177 children of 6 to 12 years old for 6 weeks treatment with placebo, Xyzal (cetirizine plus pseudoephedrine) a one-a-day dose anti-histaminics, showed a good efficacy against the seasonal allergic nasal inflammation for children, which was published in the sc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK